These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 7738190

  • 1. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
    Purcell-Huynh DA, Farese RV, Johnson DF, Flynn LM, Pierotti V, Newland DL, Linton MF, Sanan DA, Young SG.
    J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
    Véniant MM, Pierotti V, Newland D, Cham CM, Sanan DA, Walzem RL, Young SG.
    J Clin Invest; 1997 Jul 01; 100(1):180-8. PubMed ID: 9202070
    [Abstract] [Full Text] [Related]

  • 3. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA, Newland DL, Tao R, Marcovina S, Wang J, Mooser V, Hammer RE, Hobbs HH.
    Proc Natl Acad Sci U S A; 1998 Apr 14; 95(8):4544-9. PubMed ID: 9539774
    [Abstract] [Full Text] [Related]

  • 4. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).
    Callow MJ, Verstuyft J, Tangirala R, Palinski W, Rubin EM.
    J Clin Invest; 1995 Sep 14; 96(3):1639-46. PubMed ID: 7657833
    [Abstract] [Full Text] [Related]

  • 5. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.
    Cohen RD, Castellani LW, Qiao JH, Van Lenten BJ, Lusis AJ, Reue K.
    J Clin Invest; 1997 Apr 15; 99(8):1906-16. PubMed ID: 9109435
    [Abstract] [Full Text] [Related]

  • 6. Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E.
    Espinosa-Heidmann DG, Sall J, Hernandez EP, Cousins SW.
    Invest Ophthalmol Vis Sci; 2004 Jan 15; 45(1):260-6. PubMed ID: 14691182
    [Abstract] [Full Text] [Related]

  • 7. Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice.
    Mancini FP, Newland DL, Mooser V, Murata J, Marcovina S, Young SG, Hammer RE, Sanan DA, Hobbs HH.
    Arterioscler Thromb Vasc Biol; 1995 Nov 15; 15(11):1911-6. PubMed ID: 7583571
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142).
    Fazio S, Sanan DA, Lee YL, Ji ZS, Mahley RW, Rall SC.
    Arterioscler Thromb; 1994 Nov 15; 14(11):1873-9. PubMed ID: 7947615
    [Abstract] [Full Text] [Related]

  • 9. A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet.
    Powell-Braxton L, Véniant M, Latvala RD, Hirano KI, Won WB, Ross J, Dybdal N, Zlot CH, Young SG, Davidson NO.
    Nat Med; 1998 Aug 15; 4(8):934-8. PubMed ID: 9701246
    [Abstract] [Full Text] [Related]

  • 10. Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet.
    Fan J, Shimoyamada H, Sun H, Marcovina S, Honda K, Watanabe T.
    Arterioscler Thromb Vasc Biol; 2001 Jan 15; 21(1):88-94. PubMed ID: 11145938
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.
    Farese RV, Véniant MM, Cham CM, Flynn LM, Pierotti V, Loring JF, Traber M, Ruland S, Stokowski RS, Huszar D, Young SG.
    Proc Natl Acad Sci U S A; 1996 Jun 25; 93(13):6393-8. PubMed ID: 8692825
    [Abstract] [Full Text] [Related]

  • 12. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
    Véniant MM, Sullivan MA, Kim SK, Ambroziak P, Chu A, Wilson MD, Hellerstein MK, Rudel LL, Walzem RL, Young SG.
    J Clin Invest; 2000 Dec 25; 106(12):1501-10. PubMed ID: 11120757
    [Abstract] [Full Text] [Related]

  • 13. ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice.
    Voyiaziakis E, Goldberg IJ, Plump AS, Rubin EM, Breslow JL, Huang LS.
    J Lipid Res; 1998 Feb 25; 39(2):313-21. PubMed ID: 9507992
    [Abstract] [Full Text] [Related]

  • 14. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).
    Linton MF, Farese RV, Chiesa G, Grass DS, Chin P, Hammer RE, Hobbs HH, Young SG.
    J Clin Invest; 1993 Dec 25; 92(6):3029-37. PubMed ID: 8254057
    [Abstract] [Full Text] [Related]

  • 15. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
    Li H, Gu S, Cao X, Wang Z, She M.
    Chin Med J (Engl); 2000 Jul 25; 113(7):657-61. PubMed ID: 11776042
    [Abstract] [Full Text] [Related]

  • 16. Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat diets.
    Kushwaha RS, Barrett PH, Reardon CA, Lewis DS, Carey KD, Getz GS, McGill HC.
    Metabolism; 1995 Aug 25; 44(8):1058-66. PubMed ID: 7637648
    [Abstract] [Full Text] [Related]

  • 17. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM, Lee SJ, Kuriakose G, Spencer C, Becker L, Grosskopf I, Ko C, Huang LS, Koschinsky ML, Cooper AD, Tabas I.
    Arterioscler Thromb Vasc Biol; 2005 Aug 25; 25(8):1704-10. PubMed ID: 15905467
    [Abstract] [Full Text] [Related]

  • 18. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1994 Apr 25; 93(4):1403-10. PubMed ID: 8163645
    [Abstract] [Full Text] [Related]

  • 19. Dietary cholate is required for antiatherogenic effects of ethanol in mouse models.
    Deeg MA.
    Alcohol Clin Exp Res; 2003 Sep 25; 27(9):1499-506. PubMed ID: 14506412
    [Abstract] [Full Text] [Related]

  • 20. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ.
    Proc Natl Acad Sci U S A; 1996 Sep 17; 93(19):10022-7. PubMed ID: 8816744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.